Company: PCRX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050176
Chunk: 42

Company: Pacira BioSciences, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 42
---
Item 1. FINANCIAL STATEMENTS (Unaudited)

PACIRA BIOSCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS 

(In thousands, except share and per share amounts)

(Unaudited)September 30,2025December 31,2024ASSETSCurrent assets:       Cash and cash equivalents$147,589 $276,774      Short-term available-for-sale investments98,745 207,841      Accounts receivable, net115,268 113,304      Inventories, net157,680 125,282      Prepaid expenses and other current assets43,469 21,929           Total current assets562,751 745,130 Fixed assets, net147,388 167,169 Right-of-use assets, net44,266 49,222 Goodwill20,317 — Intangible assets, net382,396 425,970 Deferred tax assets120,188 130,376 Investments and other assets20,271 35,649           Total assets$1,297,577 $1,553,516 LIABILITIES AND STOCKHOLDERS’ EQUITY  Current liabilities:       Accounts payable$17,687 $19,133      Accrued expenses79,643 80,124      Lease liabilities9,748 8,887      Current portion of long-term debt, net— 201,776           Total current liabilities107,078 309,920 Long-term debt, net376,721 383,545 Lease liabilities38,839 44,645 Contingent consideration17,834 20,241 Deferred tax liabilities4,587 — Other liabilities25,304 16,817           Total liabilities570,363 775,168 Commitments and contingencies (Note 16)Stockholders’ equity:  Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September 30, 2025 and December 31, 2024— — Common stock, par value $0.001; 250,000,000 shares authorized; 47,735,248 shares issued and 42,965,902 shares outstanding at September 30, 2025 and 47,